CBLN1 and cancer: Increased Cer level was observed in response to many cancer chemotherapeutic agents, including fludarabine, vincristine, etoposide, daunorubicin, irinotecan, paclitaxel, fenretinide and doxorubicin (Senchenkov et al., 2001).